Haemonetics Corp (HAE) is a company that specializes in providing blood management solutions to healthcare providers around the world. The company offers a wide range of products and services designed to improve the efficiency and safety of blood collection, processing, and transfusion. As part of its commitment to innovation and continuous improvement, Haemonetics Corp utilizes various technical analysis tools to assess the performance and trends of its stock.

One of the key technical indicators used by Haemonetics Corp is the Relative Strength Index (RSI). This indicator measures the speed and change of price movements, helping to determine whether a stock is overbought or oversold. By analyzing the stock's RSI, Haemonetics Corp can make informed decisions about the timing of buying or selling its shares.

Haemonetics (HAE) Technical Analysis

Haemonetics Corp (HAE) technical analysis indicators include RSI, ADX, MACD, ROC, STOCHRSI, and WILLR. The RSI measures the stock's overbought or oversold conditions, while the ADX indicates the stock's trend strength. The MACD shows the stock's momentum, while the ROC measures its rate of change. The STOCHRSI and WILLR evaluate the stock's relative strength and its momentum compared to its trading range. Find out the technical analysis rating for Haemonetics Corp (HAE) using these indicators.

Haemonetics Corp (HAE) Technical Analysis: RSI, ADX, MACD, ROC, STOCHRSI, WILLR

Haemonetics Corporation, a healthcare company, provides suite of medical products and solutions in the United States and internationally. The company offers automated plasma collection systems, donor management software, and supporting software solutions including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous solutions, as well as integrated information technology platforms for plasma customers to manage their donors, operations, and supply chain; and NexLynk DMS donor management system, and Donor360. It also provides automated blood component and manual whole blood collection systems, such as MCS brand apheresis equipment to collect specific blood components from the donor; disposable whole blood collection and component storage sets; SafeTrace Tx blood bank information system; and BloodTrack blood management software, a suite of blood management and bedside transfusion solutions that combines software with hardware components, as well as an extension of the hospital's blood bank information system. In addition, the company offers hospital products comprising TEG, ClotPro, and HAS hemostasis analyzer systems that provide a comprehensive assessment of a patient's overall hemostasis; and TEG Manager software, which connects various TEG analyzers throughout the hospital, providing clinicians remote access to active and historical test results that inform treatment decisions. Further, it provides Cell Saver Elite +, an autologous blood recovery system for cardiovascular, orthopedic, trauma, transplant, vascular, obstetrical, and gynecological surgeries; and VASCADE products comprising VASCADE and VASCADE MVP, a technology platform which offers catheter-based delivery system and leverages the natural clot including collagen. The company sells its products through direct sales force, independent distributors, and sales representatives. Haemonetics Corporation was founded in 1971 and is headquartered in Boston, Massachusetts.

Haemonetics

NYSE

This suggests that the technical indicators do not strongly favor either a buying or selling stance. In such cases, investors may need to rely on additional fundamental or market analysis to make a well-informed decision.

Balanced or Uncertain

MACD

WILLR

STOCHRSI

Free

is to help users identify stocks that trade at a low value relative to their fundamentals. Suitable for value investors such as Warren Buffet.

Name	Value	Action	infoPnL (10y)
auto_graphRSI	49.13	Neutral	21.7%
auto_graphMACD	15.55	Sell	220.7%
auto_graphCCI	-55.51	Neutral	4.0%
auto_graphADX	22.30	Neutral	-
auto_graphATR	22.86	Buy	-
auto_graphWILLR	-63.93	Neutral	106.1%
auto_graphROC	-8.15	Sell	177.4%
auto_graphSTOCHRSI	0.00	Buy	318.8%

Buy	2	-75.00%
Hold	4	-50.00%
Sell	2	-75.00%

Trendlines, Support and Resistance

Welcome to Stocklytics

Technical Indicators

Indicator Ratings

Balanced or Uncertain

Haemonetics (HAE) Technical Analysis

Keep an eye on Haemonetics

Frequently Asked Questions

What are the technical signals for Haemonetics (HAE) stock based on the last 30 days?

Take Your Investments to a Whole New Level